• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6 在头颈部癌症生态系统中的作用:可能的治疗前景。

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.

机构信息

Institute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.

Department of Stomatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12801 Prague, Czech Republic.

出版信息

Int J Mol Sci. 2021 Oct 13;22(20):11027. doi: 10.3390/ijms222011027.

DOI:10.3390/ijms222011027
PMID:34681685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8540903/
Abstract

Interleukin-6 (IL-6) is a highly potent cytokine involved in multiple biological processes. It was previously reported to play a distinct role in inflammation, autoimmune and psychiatric disorders, ageing and various types of cancer. Furthermore, it is understood that IL-6 and its signaling pathways are substantial players in orchestrating the cancer microenvironment. Thus, they appear to be potential targets in anti-tumor therapy. The aim of this article is to elucidate the role of IL-6 in the tumor ecosystem and to review the possible therapeutic approaches in head and neck cancer.

摘要

白细胞介素 6(IL-6)是一种具有高度活性的细胞因子,参与多种生物学过程。此前有研究报道称,IL-6 在炎症、自身免疫和精神疾病、衰老和各种类型的癌症中发挥独特作用。此外,人们已经了解到,IL-6 及其信号通路是协调肿瘤微环境的重要参与者。因此,它们似乎是抗肿瘤治疗的潜在靶点。本文旨在阐明 IL-6 在肿瘤生态系统中的作用,并综述头颈部癌症的可能治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b6/8540903/8e806d8ae5fe/ijms-22-11027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b6/8540903/a6e54bff4194/ijms-22-11027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b6/8540903/8e806d8ae5fe/ijms-22-11027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b6/8540903/a6e54bff4194/ijms-22-11027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b6/8540903/8e806d8ae5fe/ijms-22-11027-g002.jpg

相似文献

1
IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.白细胞介素-6 在头颈部癌症生态系统中的作用:可能的治疗前景。
Int J Mol Sci. 2021 Oct 13;22(20):11027. doi: 10.3390/ijms222011027.
2
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.头颈部癌症患者接受放化疗后细胞因子的变化。
Anticancer Res. 2013 Jun;33(6):2481-9.
3
Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.白细胞介素-6表达增加预示口腔鳞状细胞癌对放化疗反应不佳及预后不良。
Oncol Rep. 2015 May;33(5):2161-8. doi: 10.3892/or.2015.3838. Epub 2015 Mar 6.
4
Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.头颈部癌症肿瘤微环境中免疫参数的临床相关性
Head Neck. 2015 Mar;37(3):449-59. doi: 10.1002/hed.23736. Epub 2014 Jul 10.
5
Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.白细胞介素 6 在获得西妥昔单抗耐药的头颈部鳞状细胞癌临床前模型中增加,但对于维持耐药性不是必需的。
PLoS One. 2020 Jan 8;15(1):e0227261. doi: 10.1371/journal.pone.0227261. eCollection 2020.
6
Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.头颈癌患者外周血单核细胞释放白细胞介素-1β和白细胞介素-6
Br J Cancer. 1993 Sep;68(3):465-8. doi: 10.1038/bjc.1993.371.
7
Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.头颈部肿瘤微环境中的趋化因子-细胞因子网络。
Int J Mol Sci. 2021 Apr 27;22(9):4584. doi: 10.3390/ijms22094584.
8
IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.白细胞介素 6 通过 JAK-STAT3-SNAIL 信号通路诱导上皮间质转化促进头颈部肿瘤转移。
Mol Cancer Res. 2011 Dec;9(12):1658-67. doi: 10.1158/1541-7786.MCR-11-0271. Epub 2011 Oct 5.
9
[B cells in head and neck oncology].[头颈部肿瘤学中的B细胞]
HNO. 2018 Apr;66(4):296-300. doi: 10.1007/s00106-018-0494-5.
10
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.西妥昔单抗治疗头颈部癌症:白细胞介素-12 和其他自然杀伤细胞激活细胞因子的免疫调节作用。
Surgery. 2012 Sep;152(3):431-40. doi: 10.1016/j.surg.2012.05.035. Epub 2012 Jul 6.

引用本文的文献

1
Gamma smooth muscle actin as a new potential marker of cancer-associated fibroblasts.γ平滑肌肌动蛋白作为癌症相关成纤维细胞的一种新的潜在标志物。
Histochem Cell Biol. 2025 Sep 19;163(1):93. doi: 10.1007/s00418-025-02419-9.
2
Head and neck tumor organoid grown under simplified media conditions model tumor biology and chemoradiation responses.在简化培养基条件下培养的头颈部肿瘤类器官可模拟肿瘤生物学特性及放化疗反应。
Sci Rep. 2025 Jul 7;15(1):24221. doi: 10.1038/s41598-025-88082-5.
3
Exploring the molecular mechanism of Xiao Ji () in treating bladder cancer using network pharmacology and molecular docking.

本文引用的文献

1
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T17 cell expansion.通过小型化、优化的嵌合可溶性 gp130 对 IL-6 转信号的选择性抑制可抑制 T17 细胞的扩增。
Sci Signal. 2021 Aug 17;14(696):eabc3480. doi: 10.1126/scisignal.abc3480.
2
Honokiol: A review of its pharmacological potential and therapeutic insights.和厚朴酚:药理学潜力及治疗见解综述。
Phytomedicine. 2021 Sep;90:153647. doi: 10.1016/j.phymed.2021.153647. Epub 2021 Jul 16.
3
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.
基于网络药理学和分子对接技术探索小蓟治疗膀胱癌的分子机制
Asian Biomed (Res Rev News). 2025 Apr 30;19(2):94-105. doi: 10.2478/abm-2025-0012. eCollection 2025 Apr.
4
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.肿瘤微环境决定头颈部鳞状细胞癌免疫治疗的预后格局:一项计算模型引导的分析
PLoS Comput Biol. 2025 Jun 3;21(6):e1013127. doi: 10.1371/journal.pcbi.1013127. eCollection 2025 Jun.
5
TRIM16 mediates secretory autophagy in head and neck cancer-associated fibroblasts.TRIM16介导头颈癌相关成纤维细胞中的分泌性自噬。
Autophagy. 2025 May 22:1-24. doi: 10.1080/15548627.2025.2508064.
6
Gene-level connections between anxiety disorders, ADHD, and head and neck cancer: insights from a computational biology approach.焦虑症、注意力缺陷多动障碍与头颈癌之间的基因水平联系:来自计算生物学方法的见解
Front Psychiatry. 2025 Mar 20;16:1552815. doi: 10.3389/fpsyt.2025.1552815. eCollection 2025.
7
Chronic Stress Mediates Inflammatory Cytokines Alterations and Its Role in Tumorigenesis.慢性应激介导炎性细胞因子改变及其在肿瘤发生中的作用。
J Inflamm Res. 2025 Jan 22;18:1067-1090. doi: 10.2147/JIR.S485159. eCollection 2025.
8
Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation.伤口愈合:通过炎症和白细胞介素-6调节深入了解自身免疫、衰老和癌症生态系统。
Front Immunol. 2024 Nov 29;15:1403570. doi: 10.3389/fimmu.2024.1403570. eCollection 2024.
9
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.肿瘤微环境决定头颈部鳞状细胞癌免疫治疗的预后格局:一项计算模型引导的分析
bioRxiv. 2024 Sep 27:2024.09.26.615149. doi: 10.1101/2024.09.26.615149.
10
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.唾液生物标志物:预测头颈癌免疫治疗反应的一种有前景的方法。
Clin Transl Oncol. 2025 May;27(5):1887-1920. doi: 10.1007/s12094-024-03742-8. Epub 2024 Oct 8.
唾液细胞因子作为口腔鳞状细胞癌生物标志物的系统评价。
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.
4
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies.在II期研究中,奥洛珠单抗用于类风湿关节炎患者且对肿瘤坏死因子抑制剂治疗反应不足时的长期安全性和疗效。
Eur J Rheumatol. 2021 Jul;8(3):120-129. doi: 10.5152/eurjrheum.2021.19207.
5
Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma.口腔鳞状细胞癌早期诊断的潜在非侵入性生物标志物
J Clin Med. 2021 Apr 13;10(8):1658. doi: 10.3390/jcm10081658.
6
Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective.植物源性甾体孕烷通过靶向细胞因子风暴和 COVID-19 中的病毒复制:一种计算机视角。
Comput Biol Med. 2021 Jul;134:104406. doi: 10.1016/j.compbiomed.2021.104406. Epub 2021 Apr 18.
7
Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy.暴露于药物的癌相关成纤维细胞促进化疗后胃癌细胞的进展。
Gastric Cancer. 2021 Jul;24(4):810-822. doi: 10.1007/s10120-021-01174-9. Epub 2021 Apr 9.
8
Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19.有争议的效果与混乱的政策:2020年(羟)氯喹治疗新冠病毒病的故事
Cochrane Database Syst Rev. 2021 Mar 25;3(3):ED000151. doi: 10.1002/14651858.ED000151.
9
A comprehensive review on anticancer mechanism of bazedoxifene.关于巴泽多昔芬抗癌机制的综合综述。
Biotechnol Appl Biochem. 2022 Apr;69(2):767-782. doi: 10.1002/bab.2150. Epub 2021 Apr 17.
10
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.皮质类固醇治疗后血浆白细胞介素-6水平作为危重症COVID-19患者重症监护病房住院时间的指标。
Cell Death Discov. 2021 Mar 15;7(1):55. doi: 10.1038/s41420-021-00429-9.